Vincent Ossipow
Director · SOPHiA GENETICS SA
Individual
- 2026
- Jun 22, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Vincent Ossipow files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jurgi Camblong - $2.65M in SOPH purchases and sales in the last 12 months
- Zhenyu Xu - $761K in SOPH purchases and sales in the last 12 months
- Philippe Menu - $478K in SOPH purchases and sales in the last 12 months
- Abhimanyu Verma - $266K in SOPH purchases and sales in the last 12 months
- Ross Muken - $225K in SOPH purchases and sales in the last 12 months
- Manuela Valente - $159K in SOPH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Vincent Ossipow?
Vincent Ossipow is a corporate insider, tracked as Director of SOPHiA GENETICS SA (SOPH). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Vincent Ossipow last file a Form 4?
The only primary Form 4 on record is dated 22 June 2026.
